Benefits of a Gluten-Free Diet for Asymptomatic Patients With Serologic Markers of Celiac Disease

GFDs benefit asymptomatic EmA-positive patients. The results support active screening of patients at risk for celiac disease. Clinicaltrials.gov no: NCT01116505.